European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope

Cel

Prostate Cancer (PCa) is the second leading cause of cancer, among men in Europe. There are currently major unmet needs in this field, such as insufficient knowledge on risk factors that contribute to PCa and on patient characteristics (including genetic profiles) that could facilitate patient stratification. Finally, there is lack of meaningful engagement of all key stakeholders, while the knowledge currently gained from clinical practice and real life data is not being fed back into PCa patients’ care pathways. There is thus a need for better definition of PCa across all stages, improved patient’s stratification at diagnosis, and standardisation of PCa-related outcomes based on real life data.

PIONEER’s unique dual approach is to first identify critical evidence gaps in PCa by respected Key Opinion Leaders, and then embark on a research priority setting exercise that reflects the needs of all key stakeholders in PCa management. To achieve this, PIONEER has brought together comprehensive datasets that consists of the most relevant prostate clinical trials and registries, large epidemiological cohorts, electronic heath records, and real-life data from different European (and non-European) patient populations. These unique data sets will be integrated, standardised, harmonised and analysed using approaches that are built on our experience of similar previous IMI projects i.e EMIF, and eTRIKS, and analysed using a unique set of methodologies and advanced analytics methods (OMOP, eHS). PIONEER has already performed a first PCa research priority setting survey, where major stakeholders were asked to identify the current unmet needs in PCa. The five most important open questions will be used as pilot studies to verify PIONEER’s research framework. As such, PIONEER’s deliverables will be outcome-driven, value-based and patient-centric, and relevant to all key stakeholders, as they would have been meaningfully involved from the inception of the project.

Dziedzina nauki

Słowa kluczowe

Program(-y)

Temat(-y)

Zaproszenie do składania wniosków

H2020-JTI-IMI2-2016-10-two-stage

Zobacz inne projekty w ramach tego zaproszenia

System finansowania

RIA - Research and Innovation action

Koordynator

STICHTING EUROPEAN UROLOGICAL FOUNDATION
Wkład UE netto
€ 797 439,28
Adres
Mr. E.N. van Kleffenstraat 5
6842 CV Arnhem
Niderlandy

Zobacz na mapie
MŚP

Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.
Tak
Region
Oost-Nederland Gelderland Arnhem/Nijmegen
Rodzaj działalności
Other
Linki
Koszt całkowity
€ 1 842 439,28

Uczestnicy (37)

Udostępnij tę stronę

Pobierz

Ostatnia aktualizacja: 20 Maja 2024

Moja broszura

Permalink: https://cordis.europa.eu/project/id/777492/pl

European Union, 2024